CLINICAL_TRIALS
trial_result
· 2024-07-09
Clinical Trial Update: QUILT-3.006 for Recurrent Medullary Thyroid Cancer [Phase 2]
Summary
Phase 2 trial QUILT-3.006 for recurrent medullary thyroid cancer has completed, with results posted in July 2024.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: NantCell, Inc. | Conditions: Medullary Thyroid Cancer (MTC) | Phase 2 | Status: COMPLETED | Results posted: 2024-07-09